Position in IQV
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$579
+$68 QoQ
Shares Held
3
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,062
of 1,077 holders
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Beaird Harris Wealth Management, LLC holds $240,610 across 9 Diagnostics & Research names. IQV ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
224 | $112,304 | |
| 2 | DHR |
Danaher Corp /De/
|
452 | $86,096 | |
| 3 | NEO |
Neogenomics Inc
|
2,225 | $32,462 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
6 | $3,177 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
6 | $3,158 | |
| 6 | GH |
Guardant Health, Inc.
|
10 | $1,500 | |
| 7 | ILMN |
Illumina, Inc.
|
6 | $1,054 | |
| 8 | IQV |
Iqvia Holdings Inc.
This page
|
3 | $579 |
All Filings in IQV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $579 | 3 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $511 | 3 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $676 | 3 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $569 | 3 | Shares | Sole | 2025-11-13 | |
| 2024-03-31 | $758 | 3 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $694 | 3 | Shares | Sole | 2024-02-27 | |
| No filing history on record for this holder in this stock. | ||||||